Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia

Other illness

• Patients with hypersensitivity to components of this drug or other dihydropyridine drugs
• a patient with severe liver failure

Lab values

• Patients with active liver disease who include continuous serum transaminase elevation of unknown cause or serum transaminase elevation over three times the upper limit of normal
• a patient with severe renal failure (CLcr, creatinine clearance \<30 mL/min)

Age

• A woman who is pregnant or likely to be pregnant, a woman of childbearing age who does not use appropriate contraception and a nursing woman

Other

• a patient with severe aortic valvular stenosis
• a myopathy patient
• a cyclosporine co-administered patient

• Aged ≥ 19 years
• Patients with hypertension and hypercholesterolemia who are receiving Rosuampin medication or need Rosuampin medication according to the medical judgment of the investigator
• Written informed consent